Melanoma is the third most common cancer in Australia for both women and men.
Melanoma begins in cells known as melanocytes. The main cause of melanoma is exposure to ultraviolet (UV) radiation. The risk of developing melanoma grows with the amount of UV exposure, especially each time you experience sunburn. It can be years and even decades before any signs of melanoma begins so it is important for all ages and all skin types to reduce UV exposure.
The Morgan Mansell Prize (Young Melanoma Researcher of the Year) is a prize initiated by Melanoma Research Victoria and awarded annually for the most outstanding… Read More »The Morgan Mansell Prize: Analysing data from AI imaging
Morgan Mansell passed away from melanoma at the age of just 25 years young in 2018. Throughout the last five years of her short life,… Read More »The Morgan Mansell Prize
One thing politicians from all sides of politics can agree on is the significant burden of skin cancer in Australia. That is why, wearing its… Read More »Parliamentary Friends of Melanoma & Skin Cancer Awareness
Craig Lawn, a Stage IV melanoma survivor, is now spearheading the battle against skin cancer with his strong voice in advocacy and research. Through his… Read More »Targeted National Screening Program for Melanoma and Skin Cancer
Today is Check4Spots Day, an initiative for all of us to ‘be all over melanoma’ in memory of 25 year old Morgan Mansell, who sadly… Read More »Check for Spots Day
Having a carer by your side will help provide emotional support through diagnosis, treatment and beyond. Most people who receive a serious skin cancer (including… Read More »The role of the carer
Pauline was 37 weeks pregnant with her second daughter when she discovered what she thought was a mole, was in fact a melanoma. Pauline shares… Read More »What they don’t tell you when you are first diagnosed with cancer
A productive and insightful trip to Munich, Germany, to meet with advocates, clinicians and researchers from around the world. MSCAN is a proud member of… Read More »MSCAN at MI-PAC 2023
Monash University researchers in Melbourne have discovered how a rogue protein produces ‘Jekyll and Hyde’ cancer cells. This exciting discovery could lead to improved treatments… Read More »New research that could lead to improved treatments for melanoma
MSCAN asked Gabrielle Byars, CEO of Melanoma and Skin Cancer Trials (MASC Trials), to explain clinical trials and what they mean for melanoma and skin… Read More »Clinical trials for melanoma and skin cancer patients